The Robotic Lung Biopsy Market size is projected to be worth USD 408.0 million in 2023. From 2023 to 2033, global robotic lung biopsy demand is forecast to rise at 9.6% CAGR. Total market valuation at the end of 2033 is expected to surpass USD 1,023.05 million.
Lung cancer remains the primary cause of cancer deaths globally. To tackle this global burden, early diagnosis becomes extremely critical. For this purpose, medical professionals perform diagnostic procedures such as biopsies and robotic lung biopsies.
Robotic lung biopsy, also known as robotic-assisted bronchoscopy or robotic bronchoscopy, is a novel advancement in bronchoscopy. It is widely used to detect the presence of lung cancer and other lung diseases.
Robotic lung biopsies use robotic-assisted technology for performing precise biopsies quickly and accurately. These procedures are minimally invasive and can be instrumental in determining the stage and type of a tumor, thereby helping to guide the course of treatment.
Rising need for early detection and diagnosis of lung cancer is providing a strong impetus to the robotic lung biopsy industry. Consequently, growing preferences towards minimally invasive medical procedures is expected to boost robotic lung biopsy sales revenue during the forecast period.
Minimally invasive procedures such as robotic lung biopsies are safer and more effective and can reduce pain, recovery time, and risk of infection. They aid in the early detection of lung cancer and other lethal respiratory diseases which can be helpful to initiate a proper treatment approach.
Surging cases of lung cancer and other respiratory disease is likely to fuel robotic lung biopsy system demand during the assessment period.
As per the World Cancer Research Fund International, there were an estimated 2.2 million lung cancer cases globally in 2020 and this number is expected to significantly increase during the next ten years. This will uplift robotic lung biopsy demand.
Introduction of favorable reimbursement policies is expected to positively impact the robotic lung biopsy industry. Many insurance providers are offering coverage for minimally invasive procedures, making them accessible and affordable to patients. As a result, more and more lung cancer patients are opting for robotic lung biopsies.
Due to the rising incidence of lung cancer and developments in robotic-assisted technology, the market for robotic lung biopsies is anticipated to expand rapidly over the next several years
Collaborations between medical device manufacturers and research institutes are anticipated to increase. This will significantly expand the global robotic lung biopsy market size.
Other Drivers Propelling the Demand for Robotic Lung Biopsy include:
Challenges for Companies /Manufacturers in the Robotic Lung Biopsy Market:
Opportunities in the Robotic Lung Biopsy Industry:
Latest Trends in the Robotic Lung Biopsy Market:
| Attributes | Key Insights |
|---|---|
| Estimated Global Robotic Lung Biopsy Market Size (2023) | USD 408.0 million |
| Projected Robotic Lung Biopsy Market Projected Value (2033) | USD 1,023.05 million |
| Value-based CAGR (2023 to 2033) | 9.6% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2018 to 2022, the global robotic lung biopsy market experienced a CAGR of 11.2% CAGR. Total market value at the end of 2022 reached around USD 379.7 million.
From 2018 to 2022, the global robotic lung biopsy industry witnessed steady growth due to the rising demand for lung cancer control systems. The market for robotic lung biopsies was just getting started at the time, and adoption rates were quite low.
Due to their high price, limited availability, and the perceived risk associated with robotic surgery, many healthcare professionals were reluctant to invest in these systems.
As per estimates from Intuitive Surgical in 2022, a total of 321 Ion end luminal systems were installed globally.
Looking ahead, the global robotic lung biopsy industry is expected to progress at a CAGR of 9.6% from 2023 to 2033. By the end of 2033, the market size is expected to reach USD 1,023.05 million.
Rising cases of lung cancer and shift towards minimally invasive procedures are key factors that are expected to drive the global market forward.
Minimally Invasive Procedures Fueling Robotic Lung Biopsy Demand in the United States
| Country | United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 648.1 million |
| CAGR % from 2023 to the End of Forecast (2033) | 10.8% |
The United States robotic lung biopsy industry is expected to reach a valuation of USD 648.1 million by 2033. Overall demand for robotic lung biopsies in the country is set to increase at a CAGR of 10.8% from 2023 to 2033.
High penetration of robotics in healthcare sector and rising preference for minimally invasive procedures are key factors boosting the United States robotic lung biopsy market.
Other factors expected to drive the demand for robotic lung biopsies in the country are:
High Adoption of Robotic Technologies in Healthcare to Boost the United Kingdom Market
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 58.5 million |
| CAGR % from 2023 to the End of Forecast (2033) | 8.2% |
Robotic lung biopsy sales revenue in the United Kingdom is expected to surge at 8.2% CAGR during the assessment period. By 2033, the United Kingdom market value is projected to cross USD 58.5 million.
Rising adoption of robotic technologies in disease diagnosis and treatment is a prominent factor driving the United Kingdom. Similarly, favorable government support will facilitate market expansion in the country.
The National Health Service (NHS) in the United Kingdom is also pushing for increased use of robotic technologies in healthcare. This is increasing both healthcare professionals' and patients' knowledge of these technologies as well as fueling adoption of cutting-edge medical equipment.
Rising Prevalence of Lung Cancer to Boost China’s Robotic Biopsy Sector
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 23.4 million |
| CAGR % from 2023 to the End of Forecast (2033) | 7.7% |
Robotic lung biopsy demand in China is anticipated to surge at 7.7% CAGR from 2023 to 2033. Total market valuation in China at the end of 2033 is expected to reach USD 23.4 million. Increasing cases of lung cancer is a key factor boosting the robotic lung biopsy industry in China.
The development of this industry is also being aided by technological and robotic developments that have made lung biopsy procedures safer, less intrusive, and more effective.
Finally, development of the robotic lung biopsy industry in China is significantly influenced by the Chinese government's support for medical technology and innovation.
Increasing Adoption of Advanced Medical Technologies Spurring Growth in Kapan Market
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 37.0 million |
| CAGR % from 2023 to the End of Forecast (2033) | 9.7% |
he robotic lung biopsy industry in Japan is estimated to reach a market share of USD 37.0 million by 2033. It is expected to thrive at a CAGR of 9.7% over the next ten years. Growing adoption of advanced medical technologies is expected to boost Japan market during the assessment period.
There is now a sizable market in Japan for precise diagnostic equipment, such as robotic lung biopsy systems. In the healthcare industry, Japan is renowned for being an early user of new technology, which has helped to fuel the quick expansion of this business.
The Japanese government also places a high priority on encouraging medical innovation and funding the creation of cutting-edge technologies. This is creating a conducive environment for robotic lung biopsy device manufacturers.
Growing Awareness About the Positive Outcomes of Robotic Lung Biopsies Fueling Demand in Korea
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 11.2 million |
| CAGR % from 2023 to the End of Forecast (2033) | 5.5% |
The robotic lung biopsy industry in South Korea is anticipated to cross a valuation of USD 11.2 million by 2033. It is likely to exhibit a CAGR of 5.5% during the forecast period.
Growth in the market is driven by continuous advancements in medical technologies and rising awareness about the benefits of robotic lung biopsies.
The government aggressively encourages the quick uptake of innovative technologies, such as robotics, in the healthcare industry. Compared to conventional approaches, robotic lung biopsy operations are more accurate and efficient, carry a lower risk of complications, and result in faster patient recovery periods.
Last but not least, South Korea's advanced and well-established healthcare system offers a favorable atmosphere for the commercial expansion of robotic lung biopsies.
Principal Consultant
Increasing Usage by End-users Fueling Demand for Instruments and Accessories
According to Future Market Insights (FI), demand in the market will remain high for instruments and accessories. The target segment is expected to progress at a CAGR of 10.9% from 2023 to 2033. This is due to rising usage of robotic lung biopsy instruments and accessories in hospitals and ambulatory surgical centers.
During a biopsy, robotic instruments and accessories are designed to allow precise and accurate tissue manipulation. The robotic arms provide surgeons with more dexterity and fine control, allowing them to make delicate movements with greater precision. This precision aids in the targeting of specific areas of interest as well as the collection of correct tissue samples for diagnosis.
Robotic systems help surgeons by converting hand movements into precise actions via robotic instruments. This decreases the physical strain and tiredness that surgeons suffer throughout extensive surgeries. The ergonomic design of the instruments and accessories allows for comfortable manipulation and enhances the surgeon's control.
Fiber Optic RealShape Navigation to Remain the Most Popular Navigation Technology
As per the latest report, fiber optic realshape navigation segment is expected to thrive at 10.4% CAGR from 2023 to 2033. It is likely to remain the most widely used technology in robotic lung biopsies. This is due to ability of this ground-breaking technology to enable real-time 3D visualization of full shape devices inside the body.
In robotics biopsy treatments, fiber optic realshape navigation provides higher accuracy, increased reach, and real-time visualization. This leads to a more successful and least invasive approach to lung biopsies.
Fiber optic realshape navigation, by generating a three-dimensional map of the patient's airways, can provide real-time advice. This assists the surgeon in precisely navigating to the desired region, increasing the likelihood of collecting a tissue sample from the intended site.
Hospitals Segment to Dominate the Global Market Through 2033
The hospitals segment is expected to dominate the robotic lung biopsy industry, accelerating at a CAGR of 9.9% from 2023 to 2033. This is due to increasing number of robotic biopsy procedures performed in hospitals.
Hospitals are increasingly recognizing the advantages of robotic biopsy procedures, such as increased accuracy & precision and less invasive approaches. As a result, there has been a rise in the adoption of robotic surgical systems for performing biopsies, including lung biopsies.
The field of robotics has seen significant advancements, leading to more sophisticated and capable robotic systems. These developments include improved robotic arms, greater imaging technology, and better ergonomics for surgeons. Robotic biopsy procedures have become more precise, efficient, and safe as a result of such advancements and hospitals are becoming key end users for advanced robotic systems.
The robotic lung biopsy industry is highly competitive, with numerous players vying for market share. In such a scenario, key players must adopt effective strategies to stay ahead of the competition.
Key Strategies Adopted by the Players
Product Innovation
Leading companies are investing in research and development to introduce advanced robotic systems and services for robotic lung biopsies. Product innovation will allow them to differentiate themselves from their competitors while also catering to the changing needs of end users
Strategic Partnerships and Collaborations
Key players frequently develop strategic partnerships and collaborations with other companies to expand their market presence. They can also gain access to new technologies and markets through such collaborations.
Expansion into Emerging Markets
The robotic lung biopsy industry is witnessing significant growth in emerging markets such as China and the United States. Key robotic lung biopsy device manufacturers are expanding their presence in these markets by establishing local manufacturing facilities and strengthening their distribution networks.
Mergers and Acquisitions
Key players in the robotic lung biopsy industry often engage in mergers and acquisitions to strengthen their market position, expand their product portfolio, and gain access to new markets.
Key Players in the Robotic Lung Biopsy Industry
Key Developments:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | USD 408.0 million |
| Projected Market Size (2033) | USD 1,023.05 million |
| Anticipated Growth Rate (2023 to 2033) | 9.6% CAGR |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value and MT for Volume |
| Key Regions Covered | North America; Latin America; Europe; Asia Pacific; and Middle East and Africa |
| Key Countries Covered | United States, Canada, Mexico, Brazil, Germany, Italy, France, United Kingdom, Spain, BENELUX, Russia, China, Japan, South Korea, India, ASEAN, Australia and New Zealand, Türkiye, South Africa, GCC Countries, Others. |
| Key Segments Covered | Product & Services, Navigation Technology, End User, and Region |
| Key Companies Profiled | Ethicon, Inc. (Johnson & Johnson); Intuitive Surgical. |
The growth potential of the market is 9.6% through 2033.
The high treatment cost is likely to limit market growth.
The United States is likely to capture a valuation of 648.1 million by 2033.
The market in the United Kingdom may capture a CAGR of 8.2% by 2033.
The United States, China, and the United Kingdom may witness significant growth in the market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value-Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD million) Analysis 2018 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product and Services 9.1. Systems 9.2. Instruments and accessories 9.3. Services 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Navigation Technology 10.1. Electromagnetic and Optical Navigation 10.2. Fiber Optic RealShape Navigation 11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 11.1. Hospitals 11.2. Ambulatory Surgical Centers 12. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East & Africa 13. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 17. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033 18. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033 19. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 20. Market Structure Analysis 21. Competition Analysis 21.1. Ethicon, Inc. (Johnson & Johnson) 21.2. Intuitive Surgical 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Robotic Lung Biopsy Market
